Oblique Therapeutics

Göteborg, Sweden

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

$1.4M raised

Jun 2026

Undisclosed

Biotechnology Health Care Hospital Medical Pharmaceutical

Top Investors

Almi Invest

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Oblique Therapeutics

How much funding has Oblique Therapeutics raised?

Oblique Therapeutics has raised $1.4M in total funding. The most recent round was Undisclosed. The last funding was announced in June 2026.

Who are Oblique Therapeutics's investors?

Oblique Therapeutics's investors include Almi Invest.

Where is Oblique Therapeutics headquartered?

Oblique Therapeutics is headquartered in Göteborg, Sweden.

What does Oblique Therapeutics do?

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

What stage is Oblique Therapeutics at?

Oblique Therapeutics is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 30, 2026.

MLA

"Oblique Therapeutics — Funding & Investors." VCBacked, June 30, 2026, https://www.vcbacked.co/company/oblique-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Oblique Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/oblique-therapeutics

Wikipedia (cite web)

{{cite web |title=Oblique Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oblique-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 30, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K